ArthroCare Sews Up an Advantage in Sports Medicine
In a rapidly growing market like the sports medicine segment of orthopedics, it pays for companies to strike early. The introduction of new technologies and a population that alternates between sedentary work weeks and extreme sports on the weekends are fueling market growth rates of 30% annually. Thus, ArthroCare Corp. didn't hesitate to snap up five-year-old Opus Medical Inc., developer of a novel suturing and anchor system for arthroscopic soft tissue repair. In sports medicine, AthroCare's largest and most established target market (spine and ear, nose & throat are its other major markets), the Opus technology will help ArthroCare increase market penetration.
You may also be interested in...
PEAK Surgical is looking to crack the OR market with its PlasmaBlade, which uses RF energy to dissect and seal tissue. But to get there it will have to go head-to-head with some of the device industry’s giants.
A business development panel representing the emerging group of mid-sized device dealmakers that are actively looking for innovative technology from small companies discusses the current state of medtech dealmaking.
In Vivo continues its series of interviewing device company executives. This time, we pick from a category that might be called "the young Turks": executives from the younger generation who are running the next-generation of major medical device companies, those that will rival if not replace the Medtronics and Guidants of the past generation. Having cut his teeth at device giant Medtronic, Mike Baker has spent the last 10 years running ArthroCare, one of the industry's next-generation leaders.